According to the latest study from BCC Research, the demand for RNA Sequencing: Technologies and Global Markets is expected to grow from $4.3 billion in 2024 to $10.3 billion by the end of 2029, at a ...
Tune Therapeutics, an epigenome-editing company based in Durham and Seattle, will be the first to initiate a human clinical trial for an epigenetic therapy for a common infectious disease.
Scientists have achieved a significant milestone generating a large collection of exome data, which include genes that code for proteins -- key to understanding health and disease.
(Alliance News) - The British government said Wednesday that it has agreed to a partnership with Qatar that will see the Gulf state invest GBP1 billion in climate technologies.